Concepedia

E. Hamilton

EH

Statistics

Publications

2

Citations

28

H-Index

2

Active since

2021

Affiliations

AstraZeneca (Switzerland)(Current)

E. Hamilton is an author at AstraZeneca (Switzerland) specializing in oncology, metastatic breast cancer treatment, and metastatic breast cancer.

Publications per year

2021–2025

2

Publications

2

VP1-2025: Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Final overall survival (OS) from the phase III TROPION-Breast01 trial

Barbara Pistilli, Komal Jhaveri, S-A. Im et al. · Annals of Oncology · 2025 · 17 citations

, , +17

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

P. Aftimos, L. Vahdat, V. Diéras et al. · UNC Libraries · 2021 · 11 citations · Full text

, , +16

1–2 of 2